IIM
LUCD icon

INTECH Investment Management’s Lucid Diagnostics LUCD Stock Holding History

INTECH Investment Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8K Sell
23,281
-10,697
-31% -$13.6K ﹤0.01% 2056
2025
Q4 		$37K Buy
33,978
+3,889
+13% +$4.35K ﹤0.01% 2282
2025
Q3 		$30.4K Sell
30,089
-6,265
-17% -$6.84K ﹤0.01% 2390
2025
Q2 		$41.8K Buy
+36,354
New +$47K ﹤0.01% 2431

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

INTECH Investment Management's LUCD Position: Q1 2026 in Review

INTECH Investment Management reduced its Lucid Diagnostics (LUCD) stake by 31% in Q1 2026, selling an estimated $13.6K and leaving 23,281 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

INTECH Investment Management first reported a position in LUCD in Q2 2025 and has held it in 4 quarters since. The position peaked at $41.8K in Q2 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • INTECH Investment Management held 23,281 shares of Lucid Diagnostics worth $26.8K as of Q1 2026.
  • INTECH Investment Management sold 10,697 Lucid Diagnostics shares in Q1 2026, an estimated $13.6K.
  • Lucid Diagnostics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #2056 holding.
  • INTECH Investment Management first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 4 quarters since.
  • INTECH Investment Management's Lucid Diagnostics position peaked at $41.8K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.